Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-18
2005-01-18
McKane, Joseph K. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S410000
Reexamination Certificate
active
06844445
ABSTRACT:
Compound of formula (I):wherein:R represents hydrogen or a group selected from alkenyl and optionally substituted alkyl,each of R1to R8, which may be identical or different, represents hydrogen or a group selected from alkyl, alkenyl, hydroxy, alkoxy, alkenyloxy, arylalkyl, arylalkoxy, carboxy, acyloxy and arylcarbonyloxy,or one of R1to R8forms with an adjacent one R1to R8an alkylenedioxy group,its optical isomers when they exist, and addition salts thereof with a pharmaceutically acceptable acid or base,with the proviso that:when R does not represent hydrogen, then at least one of R1to R8represents hydroxy or acyloxy,and the compounds of formula (I) are other than indeno[1,2-b]indol-10(5H)-one and medicinal products containing the same which are useful for treatment of disorders of the melatoninergic system.
REFERENCES:
FDA mulls drug to slow late-stage Alzheimer's [online], [retrieved on Sep. 24, 2003]. Retrieved from the Internet<URL:http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index.html>.*
Lala et al., Role of nitric oxide in tumor progression: Lessons from experimental tumors, Cancer and Metastasis Reviews, Kluwer Academic Publishers, 1998 17(1), 91-106.*
Hamrs et al. Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures, FASEB Journal (2000), 14(12), 1814-1824.*
Kevin et al., The coupling reactions of 3-acylindoles and proof of structure of the palladium(II) acetate mediated cyclization reaction product of 3-benzoyl-1-methylindole, Heterocycles (1983), 20(12), 2433-6.*
Li, et al.,Drugs of the Future,2000, 25 (9), 945-957.
Krause, et al.,Society for Neuroscience,1996, 22, No. 551.19, 1400.
Vacas, et al.,J. Pineal Res.,1992, 13, 60-65.
Cagnacci, et al.,J. Pineal Res.,1997, 22, 16-19.
Lagneux, et al.,Life Sciences,2000, 66 (6), 503-509.
Brydon, et al.,Endocrinology,2001, 142 (10), 4264-4271.
Bylesjö, et al.,International Journal of Eating Disorders,1996, 20 (4), 443-446.
Ferrari, et al.,Biol. Psychiatry,1990, 27, 1007-1020.
Mazzucchelli, et al.,Molecular Brain Research,1996, 39, 117-126.
Brown,CNS Drugs,1995, 3 (3), 209-226.
Waldhauser, et al.,Psychopharmacology,1990, 100, 222-226.
Skene, et al.,Brain Research,1990, 528, 170-174.
Monteleone, et al.,Schizophrenia Research,1992, 7, 77-84.
Erlich, et al.,J. Neurosurg.,1985, 63, 321-341.
Maurizi,Medical Hypotheses,1988, 27, 271-276.
Kopp, et al.,Behavioural Pharmacology,1999, 10, 73-83.
Kopp, et al.,Neuropharmacology,2000, 39, 1865-1871.
Rasmussen, et al.,Endocrinology,1999, 140 (2), 1009-1012.
Armstrong, et al.,Medical Hypotheses,1991, 34, 300-309.
O'Brien, et al.,Clinical Endocrinology,1986, 24, 359-364.
Motilva, et al.,Current Pharmaceutical Design,2001, 7, 909-931.
Tamarkin, et al.,Science,1985, 227, 714-720.
Chemineau, et al.,Rec. Med. Vet.,1991, 167 (3/4), 227-239.
Xu, et al.,Drug Development Research,1996, 39, 167-173.
Régrigny, et al.,Am. J. Physiol.,1998, 275, 139-144.
Stankov, et al.,Neuroscience,1993, 52 (2), 459-468.
Leone, et al.,Cephalalgia,1996, 16, 494-496.
Brun, et al.,Cephalalgia,1995, 15, 136-139.
Ying, et al.,Eur. J. of Pharmacology,1993, 246, 89-96.
Laudon, et al.,Journal of Clinical Endocrinology and Metabolism,1996, 81 (4), 1336-1342.
Lissoni, et al.,British Journal of Cancer,1996, 74, 1466-1468.
Boussard Marie-Françoise
Boutin Jean Albert
Delagrange Philippe
Rousseau Anne
Wierzbicki Michel
Anderson Rebecca
Les Laboratoires Servier
McKane Joseph K.
The Firm of Hueschen and Sage
LandOfFree
Indenoindolone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indenoindolone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indenoindolone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378219